Aerobic Exercise for Cancer
Trial Summary
What is the purpose of this trial?
This study is being done to answer the following question: Will aerobic exercise (exercise that stimulates and strengthens the heart and lungs, and improves the body's use of oxygen) change the biomarkers (signs of disease) found in the blood?
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you cannot be on any form of antitumor therapy, except for certain allowed therapies like endocrine therapy and anti-HER2 antibodies.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you cannot be on any antitumor therapy, except for certain allowed treatments like endocrine therapy and anti-HER2 antibodies.
What data supports the effectiveness of the treatment Exercise, Physical Activity, Workout, Fitness Training for cancer patients?
What data supports the effectiveness of the treatment Exercise, Physical Activity, Workout, Fitness Training for cancer patients?
Is aerobic exercise safe for cancer patients during treatment?
Is aerobic exercise safe for cancer patients during treatment?
How does aerobic exercise as a treatment for cancer differ from other treatments?
Aerobic exercise is unique because it helps cancer patients improve their physical function and quality of life by reducing fatigue and other side effects of cancer and its treatment. Unlike traditional medical treatments, it focuses on enhancing physical and emotional well-being through regular physical activity.310111213
How does aerobic exercise as a treatment for cancer differ from other treatments?
Aerobic exercise is unique because it helps cancer patients improve their physical function and quality of life by reducing fatigue and other side effects of cancer and its treatment. Unlike traditional medical treatments, it focuses on enhancing physical activity and rehabilitation, making it a supportive therapy that can be used alongside other cancer treatments.310111213
Research Team
Lee Jones, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Eligibility Criteria
This trial is for adults who have had or are having androgen deprivation therapy, breast cancer with stable disease or no evidence of disease, high risk of cardiovascular disease, stage III colorectal or breast cancer post-therapy, localized prostate cancer under active surveillance, Lynch syndrome without intense exercise habits. Exclusions include severe heart/lung conditions, mental impairment affecting cooperation, other conflicting trials.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive structured exercise therapy for 24 weeks, consisting of individualized walking delivered up to 5 times weekly, monitored via telemedicine.
Follow-up
Participants are monitored for changes in biomarkers and residual tumor burden after treatment
Treatment Details
Interventions
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Weill Medical College of Cornell University
Collaborator
University of California, Los Angeles
Collaborator